1kjl: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1kjl.gif|left|200px]]
{{Seed}}
[[Image:1kjl.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1kjl|  PDB=1kjl  |  SCENE=  }}  
{{STRUCTURE_1kjl|  PDB=1kjl  |  SCENE=  }}  


'''High Resolution X-Ray Structure of Human Galectin-3 in complex with LacNAc'''
===High Resolution X-Ray Structure of Human Galectin-3 in complex with LacNAc===




==Overview==
<!--
The high-resolution X-ray crystal structures of the carbohydrate recognition domain of human galectin-3 were solved in complex with N-acetyllactosamine (LacNAc) and the high-affinity inhibitor, methyl 2-acetamido-2-deoxy-4-O-(3-deoxy-3-[4-methoxy-2,3,5,6-tetrafluorobenzamido ]-beta-D-galactopyranose)-beta-D-glucopyranoside, to gain insight into the basis for the affinity-enhancing effect of the 4-methoxy-2,3,5,6-tetrafluorobenzamido moiety. The structures show that the side chain of Arg144 stacks against the aromatic moiety of the inhibitor, an interaction made possible by a reorientation of the side chain relative to that seen in the LacNAc complex. Based on these structures, synthesis of second generation LacNAc derivatives carrying aromatic amides at 3'-C, followed by screening with a novel fluorescence polarization assay, has led to the identification of inhibitors with further enhanced affinity for galectin-3 (K(d) &gt; or = 320 nM). The thermodynamic parameters describing the binding of the galectin-3 C-terminal to selected inhibitors were determined by isothermal titration calorimetry and showed that the affinity enhancements were due to favorable enthalpic contributions. These enhancements could be rationalized by the combined effects of the inhibitor aromatic structure on a cation-Pi interaction and of direct interactions between the aromatic substituents and the protein. The results demonstrate that protein-ligand interactions can be significantly enhanced by the fine-tuning of arginine-arene interactions.
The line below this paragraph, {{ABSTRACT_PUBMED_15701008}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 15701008 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_15701008}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Sorme, P.]]
[[Category: Sorme, P.]]
[[Category: Lacnac complex]]
[[Category: Lacnac complex]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 22:49:13 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 10:26:07 2008''